SLC41A1 and neoplasm: Addition of the caspase inhibitor Z-VAD-FMK (50 μM) significantly attenuated the proliferation inhibition induced by SLC41A1 overexpression in PDAC cells (Figure 4D), indicating that SLC41A1-associated switch towards the apoptotic phenotype was important in mediating the tumour-suppressive functions of the protein.